Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-22 · accession 0001878313-25-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-23 | 2025-12-22 | MAIA | CHAOUKI STEVEN M | Dir | P - Purchase | $1.22 | +40.8K | 151.9K | +37% | +$49.8K |
| D | 2025-12-23 | 2025-12-22 | MAIA | CHAOUKI STEVEN M | Dir | P - Purchase | $1.36 | +40.8K | 40.8K | New | +$55.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | P | A | 40,849 | $1.22 | 151,873 | D | — | — | (F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. |
| 2 | Derivative | Stock Options | 2025-12-22 | P | A | 40,849 | $1.36 | 40,849 | D | $1.36 · 2026-06-22 to 2028-12-22 | 40,849 Common Stock | (F2) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date. |